Friday, December 29, 2017

Hypersensitivity Pneumonitis A Perspective From Members of the Pulmonary Pathology Society

Ross MillerMDTimothy Craig AllenMD, JDRoberto J. BarriosMDMary Beth BeasleyMDLouise BurkeMDPhilip T. CagleMD;Vera Luiza CapelozziMD, PhDYimin GeMDLida P. HaririMD, PhDKeith M. KerrBSc, MBChB, FRCPath, FRCPEAndras KhoorMDBrandon T. LarsenMD, PhDEugene J. MarkMDOsamu MatsubaraMD, PhDMitra MehradMDMari Mino-KenudsonMD;Kirtee RapariaMDAnja Christiane RodenMDPrudence RussellMBBS (Hons), FRCPAFrank SchneiderMDLynette M. ShollMDMaxwell Lawrence SmithMD
Reprints: Timothy Craig Allen, MD, JD, Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555 (email: ).
The authors have no relevant financial interest in the products or companies described in this article.
Context.— Hypersensitivity pneumonitis (HP) is a lung disease that develops in susceptible individuals after inhalational exposure to an organic antigen or chemical compound. Pathogenesis is attributed to a combination of type III (immune complex–mediated) and type IV (delayed) hypersensitivity reactions to the inciting agent.
Objective.— To provide an overview of the current status of the medical literature regarding hypersensitivity pneumonitis.
Data Sources.— A literature search was performed using PubMed and Google search engines. The terms “hypersensitivity pneumonitis” and “extrinsic allergic alveolitis” were used, with the search starting on January 9, 2017, and concluding March 8, 2017.
Conclusions.— As a pathologist, it is important to consider hypersensitivity pneumonitis when examining lung specimens because it is often clinically and pathologically overlooked. Recognizing the often subtle findings and correlating them with the patient's history or suggesting a thorough clinical investigation of potential exposures can be of help in identifying the underlying condition so that the patient can be appropriately managed.

No comments:

Post a Comment